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Abstract
We describe the population structure of a representative collection of 3,133 Mycobacterium
tuberculosis isolates, collected within the framework of a national resistance survey from
2007 in China. Genotyping data indicate that the epidemic strains in China can be divided
into seven major complexes, of which 92% belonged to the East Asian (mainly Beijing
strains) or the Euro-American lineage. The epidemic Beijing strains in China are closely
related to the Beijing B0/W148 strain earlier described in Russia and a large cluster of these
strains has spread national wide. The density of Beijing strains is high in the whole of China
(average 70%), but the highest prevalence was found North of the Yellow river. The Euro-
American lineage consists of three sublineages (sublineage_1, 2, and 3) and is more preva-
lent in the South. Beijing lineage showed the highest cluster rate of 48% and a significantly
higher level of resistance to rifampicin (14%, p<0.001), ethambutol (9%, p = 0.001), and
ofloxacin (5%, p = 0.011). Within the Euro-American Lineage, sublineage_3 revealed the
highest cluster rate (28%) and presented a significantly elevated level of resistance to strep-
tomycin (44%, p<0.001). Our findings suggest that standardised treatment in this region
may have contributed to the successful spread of certain strains: sublineage_3 in the Euro-
American lineage may have thrived when streptomycin was used without rifampicin for treat-
ment, while later under DOTS based treatment, in which rifampicin plays a key role, Beijing
lineage appears to be spreading.
Introduction
Among other countries in the world, China has the third highest prevalence of tuberculosis
(TB) and the second largest number of multidrug resistant tuberculosis cases (MDR-TB) in
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the world, with a WHO estimated burden of 1.2 million TB and 52,000 MDR-TB cases in 2014
[1]. Despite this heavy burden of tuberculosis, there is a relatively underdeveloped knowledge
on the key elements of the causative Mycobacterium tuberculosis epidemic strains, also in rela-
tion to the large problem of drug resistance in China.
The global population of M. tuberculosis bacteria has been divided into seven major lineages
based on genomic large sequence polymorphisms or single nucleotide polymorphism [2,3].
Distribution of lineages was found to be phylogeograghically and host associated [2]. Using
spoligotyping, the Beijing genotype was first described in 1995 [4]. Later studies have reported
that ‘Lineage 2’, also referred to as ‘East Asian lineage’ and almost entirely consisting of Beijing
genotype strains, is predominant in the Far East and overall causes more than 60% of the
tuberculosis cases in this region [2,5].
Though whole genome sequencing has shown the highest resolution in studying transmis-
sion and could provide the most detailed view of the genotype diversity, lack of an interna-
tional standardization, and shared approaches in universal software for analysis and database
tools, and the financial burden have so far limited its wide implementation, especially in a high
burden environment [6]. On the other hand, almost all Beijing strains share the same spoligo-
typing pattern, which makes spoligotyping an unsuitable tool to study the inner-population
genetic diversity of the Beijing strains. For the non-Beijing M. tuberculosis strains in China,
primarily from the Euro-American lineage, spoligotyping has been found to be unreliable for
identification of this lineage, resulting in confusing and inaccurate assignment of strains [7,8].
Thus the introduction of a more powerful and yet robust genotyping method to investigate the
population structure of M. tuberculosis in China is vital. Variable-number-tandem-repeats
(VNTR units) are microsatellite-like sequences in the M. tuberculosis genome and are widely
used to study the population structure and transmission of this microorganism. The 24 loci
VNTR typing serves as an international gold standard and has been implemented in many
molecular epidemiological studies on tuberculosis [9]. It has shown robustness to investigate
the population structure of M. tuberculosis [9–12]. However, it has so far not been widely
applied in China for analysis of the molecular epidemiology of tuberculosis. Moreover, most
data that is available is not based on nationwide, representative sampling.
Genetic lineages have been reported to be associated with different levels of pathogenicity
and resistance [13–15]. Insights into the genetic background of bacteria can help to under-
stand M. tuberculosis prevalence and transmission [16]. We therefore performed the interna-
tionally standardized 24 loci VNTR typing on more than three thousand M. tuberculosis
samples collected throughout the country in the 2007 nationwide drug resistance survey, to
investigate the population structure of this bacterium, and the relationship between the epi-
demic M. tuberculosis strains and drug resistant tuberculosis in China.
Materials and methods
Strain collection
All strains were collected within the framework of the first nationwide drug resistance baseline
survey in 2007[17]. Briefly, a cluster-randomized sampling method was used to obtain a repre-
sentative sampling of patients. Seventy sampling sites (counties) were selected in proportion
with the number of reported smear positive cases in 2004 and 2005 in each province, and at
least one site in each province was included. The sample size was determined to represent the
estimated rifampicin resistance prevalence (6% in new and 16% in retreated patients). At each
site, 51 new patients and 17 retreated patients were recruited if the smear result was positive
during a period of nine months from April to December in 2007, or until the required number
was met.
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Laboratory methods
The proportional method on Lo¨wenstein-Jensen medium was applied to test the susceptibility
to four first-line drugs (rifampicin, isoniazid, streptomycin, and ethambutol) and two second-
line drugs (kanamycin and ofloxacin) according to the WHO guidelines. Kanamycin was cho-
sen over amikacin and capreomycin due to the availability in clinical practice, and because of
the critical concentration for amikacin on solid media of proportional method not available
yet by 2008 when the drug susceptibility was tested. Para-nitro benzoic acid (PNB) and Thio-
phene-2carboxylic acid hydrazide (TCH) medium tubes were used for identification of the
species M. tuberculosis. Spoligotyping and standardized 24 loci VNTR typing was carried out
according to the protocol [9,18]. Capillary electrophoresis was used to determine the length of
the PCR fragments for MIRU-VNTR test. For samples of which amplification failed at one or
more loci, the whole procedure was repeated at least twice. Samples that failed to produce a
band at any locus, or showed more than one band at any locus, were excluded from the subse-
quent analysis.
Data analysis
Results of spoligotyping were compared to the SITVIT2 database (http://www.pasteur-
guadeloupe.fr:8081/SITVIT_ONLINE/) to assign strains to clades [19]. A cluster was defined
as two or more strains with identical VNTR patterns. All the VNTR patterns were compared
with that of the reference strains in the MIRU-VNTRplus website database (http://www.miru-
vntrplus.org/MIRU/index.faces) to identify their lineages by similarity and assigned a MLVA
code for each pattern if possible [20]. Similarity between VNTR patterns and reference strains
was measured by categorical distance which was defined by dividing the number of loci differ-
ing between the two by the total number of MIRU-VNTR loci. When the genotype was not
represented in the reference database, spoligotyping was used to assigned the genotype to a
known lineage. Cluster rate was defined as nc/N, in which N is the total number of strains in
the sample, and nc is the total number of clustered strains. BioNumeric 5.0 was used to produce
a minimum spanning tree on basis of the 24 loci VNTR typing results with categorical method.
The criterion for categorizing a complex was set to at most differences at any three of these 24
loci to best reflect the topology of the minimum spanning tree. The association between drug
resistance level and genotypes were analysed with Chi-square test or Fisher exact test. Admin-
istrative boundaries were provided by the National Key Project (2014ZX10003002).
Ethical review
This study was approved by the Tuberculosis Research Ethics Review Committee of the China
CDC. All included patients signed an informed consent form.
Results
In total, 3,929 isolates were collected from sputum smear positive tuberculosis patients with
drug susceptibility test results from 70 counties in 31 provinces in the 2007 survey. VNTR typ-
ing was performed on 3,703 isolates available in our strain bank. For 143 (3.9%) isolates, multi-
ples bands were detected at one or more loci and were excluded from further analysis. Another
427 (11.5%) isolates had one or more loci that failed PCR amplification for VNTR typing,
though there may be several explanations for the failure, the exact causes were not the focus of
this paper, so these strains were just excluded for the stringency of analysis. Finally, 3,133
(84.6% of the total) strains had a complete and single VNTR pattern and were included in the
analyses.
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There were 1,930 unique VNTR patterns and 290 clusters with identical VNTR types (VT)
observed (S1 Table). In total 1,203 strains were clustered in clusters of 2 to 133 strains. Of
these 290 clusters, 219 (75.5%) clusters, including the largest cluster of 133 isolates (VT007),
comprised only Beijing genotype strains (894 in total). The five largest clusters (>20) were
almost all Beijing strains except one strain from Manu2 and another strain from T1.
We constructed a minimum spanning tree on basis of 2,220 VNTR patterns and identified
seven major complexes of more than 10 strains, each complex consisting of strains which var-
ied maximally at 3 loci (Fig 1). Among the largest complex(n = 2208), almost all (n = 2206) of
these strains was identified as Beijing lineage with an average distance to Beijing reference
strains of 0.07 (corresponding to difference at 1.7 locus among 24 loci on average). Of these
strains, 94% (n = 2079) was also confirmed by spoligotyping as Beijing lineage and 98% (n =
2154) if only by spoligotyping. Henceforward, the largest complex was named Beijing lineage.
The following three complexes basically represented three genetically distinct sub-lineages in
the Euro-American lineage, including T, S, Haarlem, LAM, and Manu clades as defined by
spoligotyping and named as Euro-American sublineage_1, 2, and 3, sequentially. Compared to
MIRU-VNTRplus database, Euro American sublineage_1 (n = 345) was distinguished from
other lineages but similar to the New-1 strains in the MIRU-VNTRplus database. Euro Ameri-
can sublineage_2 (n = 225) was also different from other lineages but relatively close to S
strains. Euro American sublineage_3 (n = 116) was closely related to URAL and TUR strains.
The first four complexes represented 92% of the whole sample. The last three complexes were
relatively small complexes, which were primarily consisted of strains close to Delhi /CAS
strains (n = 21), Manu_ancestor strains (n = 14), and EAI strains (n = 10), respectively.
Beijing lineage was predominant in all provinces and varied from 44% to 93% of the sam-
pled strains, with an average prevalence of 70% nationwide. The highest density was observed
in the provinces north of Yellow River (Fig 2) and the lowest was observed in Xinjiang prov-
ince in the northwest of China. Euro-American lineage was most common in the area south of
the Yellow River, with a rather even distribution of these three sublineages in this area; the
highest density of these sublineages was seen in the Southwest. The north western Xinjiang
province had a unique distribution of genotypes with a complex composition, as the majority
of Delhi/CAS lineage strains (62%) were found in Xinjiang. It is possible that Central Asia is
the origin of these Delhi/CAS strains. In contrast, Manu_ancestor and EAI lineages strains
Fig 1. Minimum spanning tree based on 24 loci VNTR. Complexes was defined by difference at 3 or less
loci of the 24 VNTR pattern. Lineage name was assigned by comparing to MIRU-VNTRplus database, or by
spoligotyping for Manu_ancestor strains.
https://doi.org/10.1371/journal.pone.0174197.g001
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were most common in the South East coast provinces, indicating that a foreign origin from
oversea is likely for these strains.
Strains with identical VNTR patterns were not geographically contained. For example, the
largest cluster VT007, with the MLVA code 1048–32, comprising 133 strains, was observed in
51 (out of 70) counties and in 26 (out of 31) provinces. The largest number of VT007 strains
by county was seven, and was found in two counties. The largest five clusters together, each
comprising 20 or more of Beijing lineage strains and only differing at one or two VNTR loci,
were retrieved from 66 sites in 28 provinces (Table 1).
Significant differences in the prevalence of drug resistance were observed between the com-
plexes (Table 2). Beijing lineage had the highest proportion of members resistant to rifampicin,
isoniazid, ethambutol and ofloxacin (14%, 22%, 9% and 5%, respectively). It also revealed the
highest correlation with MDR-TB rate (12%), followed by Euro-American sublineage_1 (9%),
Euro-American sublineage_3 (6%) and then Euro-American sublineage_2 (4%). Euro-Ameri-
can sublineage_3 appeared to contain more members resistant to streptomycin (44%) or kana-
mycin (4.3%) than the other three complexes; 31% of Euro-American sublineage_3 strains
Fig 2. Geographic distribution of the complexes in 31 provinces in mainland of China.
https://doi.org/10.1371/journal.pone.0174197.g002
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were streptomycin mono-resistant, which was more than that in any other major complex.
Streptomycin mono resistance varied from 11% to 22% in the other complexes tested.
We also compared the proportion of strains with resistance to streptomycin and/or rifampi-
cin in each complex (Table 3). Interestingly, we observed no significant difference in rifampi-
cin resistance in the absence of streptomycin resistance among these four largest complexes
(p = 0.411), although we again observed a significant difference in streptomycin resistance in
rifampicin sensitive strains of the different complexes, with the highest proportion of 41% in
Euro-American sublineage_3 and the lowest of 18% in Beijing lineage(p<0.001). On the con-
trary, resistance to both streptomycin and rifampicin was highest in Beijing lineage (9%) and
lowest in Euro-American sublineage_3 (3%, p = 0.008). Accordingly, MDR strains in Beijing
lineage showed higher resistance level to streptomycin (74%, 196/266) than non-MDR strains
in Beijing lineage (21%, 406/1942, p<0.001); while this difference was not significant in Euro-
American sublineage 3 (57%, 4/7 and 43%, 47/109, respectively; p = 0.698).
Complexes also revealed different degrees in clustering (Table 4). The overall cluster rate
was 38%. Beijing lineage showed the highest cluster rate (48%, p<0.001). Within Euro-Ameri-
can lineage, the three sublineages also differed significantly in degree of clustering: Euro-
Table 1. Five most prevalent genotypes with more than 20 strains in each genotype
MIRU-VNTR genotypes MIRU-VNTR code* No. of strains in cluster MLVA code# Clade in spoligotyping
VT 007 273335444432658253213423 133 1048–32 Beijing (133)
VT 028 273335444432558253213423 83 342–32 Beijing (82), Manu2(1)
VT 111 273235444432658253213423 35 204–32 Beijing (34), T1(1)
VT 064 273335444432458253213423 32 898–32 Beijing (32)
VT 048 273335444432657253213423 25 100–32 Beijing (25)
*Order of VNTR loci: MIRU4, MIRU26, MIRU40, MIRU10, MIRU16, MIRU31, Mtub04, ETRC, ETRA, Mtub30, Mtub39, QUB4156, QUB11b, Mtub21,
QUB26, MIRU02, MIRU23, MIRU39, MIRU20, MIRU24, MIRU27, Mtub29, ETRB, Mtub34. The differences between clusters were shown in underlined.
#: MLVA code was given by MIRU-VNTRplus database, which is composed of a digital code for 15 loci VNTR pattern in the front and a digital code for 9 loci
VNTR pattern in the end.
https://doi.org/10.1371/journal.pone.0174197.t001
Table 2. Drug resistance per complex.
Drug* Beijing lineage
(n = 2208)
Euro-American sublineage_1
(n = 345)
Euro-American sublineage_2
(n = 225)
Euro-American sublineage_3
(n = 116)
P-
value#
number of strains (%, 95%CI)
Pan-
susceptible
1389 (62.9,60.9–
64.9)
221 (64.1,58.8–69.1) 131 (58.2,51.5–64.7) 56 (48.3,38.9–57.8) 0.006
Any resistance
Isoniazid 476 (21.6,19.9–23.3) 61 (17.7,13.8–22.1) 38 (16.9,12.2–22.4) 18 (15.5,9.5–23.4) 0.08
Streptomycin 602 (27.3,25.4–29.2) 85 (24.6,20.2–29.5) 75 (33.3,27.2–39.9) 51 (44.0,34.8–53.5) <0.001
Ethambutol 195 (8.8,7.7–10.1) 18 (5.2,3.1–8.1) 11 (4.9,2.5–8.6) 4 (3.4,0.9–8.6) 0.007
Rifampicin 304 (13.8,12.4–15.3) 32 (9.3,6.4–12.8) 13 (5.8,3.1–9.7) 8 (6.9,3.0–13.1) <0.001
Kanamycin 45 (2.0,1.5–2.7) 6 (1.7,0.6–3.7) 2 (0.9,0.1–3.2) 5 (4.3,1.4–9.8) 0.195
Ofloxacin 107 (4.8,4.0–5.8) 9 (2.6,1.2–4.9) 6 (2.7,1.0–5.7) 0 (0.0,0.0–3.1) 0.013
MDR 266 (12.0,10.7–13.5) 31 (9.0,6.2–12.5) 10 (4.4,2.2–8.0) 7 (6.0,2.5–12.0) <0.001
XDR 19 (0.9,0.5–1.3) 1 (0.3,0.0–1.6) 1 (0.4,0.0–2.5) 0 (0.0,0.0–3.1) 0.464
* pan-susceptible means susceptible to all six drugs tested; MDR, resistant to at least rifampicin and isoniazid; XDR were also MDR strains and plus
resistance to ofloxacin and streptomycin/kanamycin.
# P-value refers to the comparison of the resistance level in each complex and was calculated with Chisq-test or Fisher exact test.
https://doi.org/10.1371/journal.pone.0174197.t002
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American sublineage_3 had the highest clustering proportion (28%), while Euro-American
sublineage_2 had the lowest (10%).
Discussion
Previous studies have shown that Beijing lineage was predominant in China, followed by
Euro-American lineage [5,21,22]. Whole genome sequencing and MIRU-VNTR was also uti-
lized in several studies looking into the phylogeny and transmission of M. tuberculosis in
China, but at a smaller scale and with different sampling schemes [23–25]. To investigate the
epidemic strains in China and the relation between genotypes and drug resistance, we per-
formed the standardized method 24 loci MIRU-VNTR on the most representative yet largest
sample so far to determine the population structure of M. tuberculosis at a nationwide scale.
We demonstrate there are seven major genotype complexes circulating in China based on
VNTR and spoligotyping, which are all members of five major lineages: the largest complex
Beijing lineage; three sublineages or complexes within Euro American lineage, and three rela-
tively small complex representing Delhi/CAS, Manu_ancestor, and EAI lineage, respectively
[19,26].
As previously reported, the Beijing lineage is the predominant lineage in China, followed by
Euro American lineage [5,9]. Our study indicates that these two major lineages are wide spread
nationwide in China, but revealed differences in their distribution. With some exceptions, dif-
ferences in the prevalence of these two lineages roughly followed the Yellow River. This is
interesting from the perspective of the dynamics of the TB epidemic in China. One possible
underlying reason is that Beijing lineage in China originated in the North, while the Euro
American lineage originated in the South. Previous studies reported that the high genetic
Table 3. Streptomycin and rifampicin resistance per complex.
Drug
resistance*
Beijing lineage
(n = 2208)
Euro-American sublineage_1
(n = 345)
Euro-American sublineage_2
(n = 225)
Euro-American sublineage_3
(n = 116)
P-
value#
Number of resistant strains(%,95%CI)
Susceptible 1510 (68.4%,68.1–
68.7)
243 (70.4%,69.9–71.1) 145 (64.4%,64.0–65.2) 61 (52.6%,51.7–53.4) <0.001
SM-R/RIF-S- 394 (17.8%,17.6–
18.2)
70 (20.3%,19.7–20.9) 67 (29.8%,29.3–30.5) 47 (40.5%,39.7–41.4) <0.001
SM-S/RIF-R 96 (4.3%,4.1–4.7) 17 (4.9%,4.3–5.6) 5 (2.2%,1.8–3.0) 4 (3.4%,2.6–4.3) 0.411
SM-R/RIF-R 208 (9.4%,9.1–9.8) 15 (4.3%,3.8–5.0) 8 (3.6%,3.1–4.3) 4 (3.4%,2.6–4.3) 0.008
* susceptible strains were susceptible to both streptomycin (SM) and rifampicin (RIF); SM-R/RIF-S strains were resistant to streptomycin but susceptible to
rifampicin; SM-S/RIF-R strains were resistant to rifampicin but susceptible to streptomycin; SM-R/RIF-R strains were resistant to both streptomycin and
rifampicin.
# P-value refers to the comparison of the resistance level in each complex and was calculated with Chisq-test or Fisher exact test.
https://doi.org/10.1371/journal.pone.0174197.t003
Table 4. Cluster rate in different genotypes.
Genotypes No. of cases No. of clustered cases Cluster rate
% 95% CI
Beijing lineage 2208 1061 48 46.0–50.2
Euro-American sublineage_1 345 65 19 14.9–23.
Euro-American sublineage_2 225 23 10 6.6–14.9
Euro-American sublineage_3 116 33 28 20.5–37.6
Other complexes 239 21 9 5.5–13.1
https://doi.org/10.1371/journal.pone.0174197.t004
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diversity of Beijing genotypes in Japan is consistent with their likely origin in this region, indi-
cating a more ancient common ancestor for the Beijing genotype strains in North-Eastern Asia
[27,28]. Conversely, some studies have detected Beijing (like) strains with a full spoligotyping
pattern and a RD105 deletion or “extended” RD105 deletion in Southwest of China, which
would be consistent with the common ancestor of the currently expanding Beijing strains origi-
nating from this region [23,29]. This hypothesis is also supported by the study by Luo et al.
using whole genome sequencing and the study by Yin et al. using 24 loci MIRU-VNTR [23,30].
However, yet another study suggests that the deletion of the 1–34 spacers in spoligotyping may
have happened before the RD105 deletion [31]. This would make the Southwest China “ances-
tor” type of Beijing family unlikely to be the real ancestor and instead implies the RD105 region
has been independently lost at least twice. Nonetheless, a study with a global sample of thou-
sands of Beijing strain supports the Far East origin of Beijing genotype [32]. All these results
together indicate that Beijing genotype now present globally may indeed originate from East
Asia, but the detailed history of divergence and spread needs to be further addressed.
Nearly 90% of all rifampicin resistant strains are multidrug resistant [17]. A previous report
has shown that Beijing strains isolated from MDR-TB cases were associated with streptomycin
resistance [33]. So we further looked into the interactions of these two drugs with genotypes.
We observed a higher level of resistance to rifampicin and streptomycin in Beijing lineage and
Euro-American sublineage_3, respectively. However, the proportion of strains resistant to
both drugs were significantly higher in Beijing lineage than in Euro-American sublineage_3.
Streptomycin was the first antibiotic used to treat tuberculosis and was first introduced into
China in 1947[34,35]. Unfortunately, after initial clinical improvement in the first few months,
drug resistance in patients treated with streptomycin as a mono therapy frequently developed
[34]. Combined treatment by four drugs, including rifampicin, isoniazid, pyrazinamide and
ethambutol was developed in 1970s, which increased the cure rate and reduced the relapse rate
[36,37]. However, MDR-TB as a consequence of this treatment regimen was recognized in the
1990s and prompted the declaration of the WHO on tuberculosis being a global health emer-
gency. Standardised treatment is a strong selective pressure and we assume that the population
structure of the prevalent M. tuberculosis strains has been influenced by the emergence of drug
resistance. When streptomycin was first introduced, it appears to have resulted in the expan-
sion of some lineages, Euro-American sublineag_3 for example. This would imply that Euro-
American sublineage_3 has an increased potential to develop streptomycin resistance, while
maintaining virulence and the ability to spread, which is also consistent with the higher cluster
rate of Euro-American sublineage_3 compared to other sub-lineages, as these streptomycin
resistant strains remain present in our current sample and seem to continue to spread. Later
on, when treatment by rifampicin was introduced, this lineage, especially the part resistant to
streptomycin in this complex, appears to have been less successful at generating resistance to
the new drugs than another complex, Beijing lineage in this case. The latter complex showed a
higher capability to escape the antimicrobial activity of rifampicin and restore virulence when
compared to other complexes, even with already acquired resistance to streptomycin as shown
in our dataset. This is in line with the recently observed remarkable tolerance of Beijing geno-
type strains to rifampicin, as shown in advanced proteomics experiments[38,39]. Potentially,
this is a very important observation, as it would imply that specific lineages were better at
adapting to specific treatment regimens. Especially, according to our data, MDR Beijing strains
appears to have a higher potential to be resistant to streptomycin than non MDR Beijing
strains and other genotypes, which may be important when treat previously failed MDR-TB
patients infected with Beijing strains, since three out of the five antibiotics in the standard
regime for retreatment patients were likely to be ineffective [40]. However, this issue needs to
be further addressed and ideally explained by in vitro and in vivo experiments.
Association between genotype and drug resistance of Mycobacterium tuberculosis strains in China
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We found several large clusters of strains with identical VNTR patterns spreading in wide
geographic regions. Although we have not investigated the actual epidemiological links
between these clustered cases, it is reasonable to infer that such large scale links will be rather
hard to establish. We assume these strains with identical VNTR pattern are genetically closely
related and successful strains which are able to spread in diverse locations. In support of this,
the VT048 signature, which belongs to the most prevalent Beijing B0/W148 cluster in North-
west Russia and East Europe, corresponding to the MLVA code 100–32 in the MIRU-VNTR-
plus database, was also the fifth largest cluster in our sample [41,42]. This genotype has been
reported circulating in China in previous studies [23,30]. Moreover, in total 688(21%) strains
in our sample, including the other four largest clusters, differed only at one or two loci from
this genotype, indicating the epidemic Beijing strains in China are genetically very closely
related to the Beijing B0/W148 strains in Russia. Beijing B0/W148 strains were reported to
show stronger association with MDR-TB and higher transmissibility [43–46]. Accordingly,
these regions with a high prevalence of Beijing B0/W148 strains were also reported to have a
heavy MDR-TB burden, indicating this closely related group of strains appears to be able to
successfully generate resistance to the current standard therapy while they remain transmissi-
ble in certain settings [1,46]. Searching through literature, we found these epidemic strains in
China were previously also reported in Europe and North Africa but at a low prevalence, sug-
gesting these clusters are globally wide spread but with different levels of adaptation in differ-
ent areas [47,48].
From this study we have shown strong evidence of association between genotypes and drug
resistance with the largest sample ever been collected in China so far. Meanwhile, the finding
that there are different distributions of drug resistance in different bacterial genotypes also
raised the probability that standardised, possibly sub-optimal treatment regimens may result
in the selection of specific strains, as indicated by previous studies [49,50]. Though some ques-
tions, such as the origin and driving force of the spread of the Beijing genotype, as well as the
circulation of some extremely large clusters in China (and beyond), still remain to be eluci-
dated by further investigation with appropriate methods, whole genome sequencing for exam-
ple, an awareness of the differences in the biology and epidemiology between different M.
tuberculosis (sub) lineages will help to understand the nature of the circulating strains and deal
with this ancient, yet continuously developing threat to public health.
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